Oestrone‐targeted liposomes for mitoxantrone delivery via oestrogen receptor – synthesis, physicochemical characterization and in‐vitro evaluation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2017-04-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/jphp.12736PMID 28444771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.

  2017cited by this paper
• Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.

  2017cited by this paper
• A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.

  2016cited by this paper
• Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma model.

  2016cited by this paper
• PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.

  2016cited by this paper
• PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination.

  2016cited by this paper
• Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.

  2016cited by this paper
• Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.

  2016cited by this paper
• Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance.

  2016cited by this paper
• Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.

  2016cited by this paper
• Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer.

  2015cited by this paper
• Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.

  2015cited by this paper
• Fludarabine–Mitoxantrone–Rituximab regimen in untreated indolent non‐follicular non‐Hodgkin's lymphoma: experience on 143 patients

  2015cited by this paper
• A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.

  2015cited by this paper
• Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.

  2015cited by this paper
• Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.

  2015cited by this paper
• Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor

  2015cited by this paper
• Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer.

  2014cited by this paper
• An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.

  2014cited by this paper
• pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.

  2014cited by this paper
• Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.

  2014cited by this paper
• Nanoparticles containing insoluble drug for cancer therapy.

  2014cited by this paper
• Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo

  2014cited by this paper
• Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone

  2013cited by this paper
• Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.

  2013cited by this paper
• Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

  2012cited by this paper
• Expression of estrogen receptors in gastric cancer and their clinical significance

  2012cited by this paper
• Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.

  2012cited by this paper
• Molecular docking studies of quercetin and its analogues against human inducible nitric oxide synthase

  2012cited by this paper
• PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.

  2012cited by this paper
• Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.

  2012cited by this paper
• Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia

  2011cited by this paper
• Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

  2011cited by this paper
• Viral specific cytotoxic T cells inhibit the growth of TfR-expressing tumor cells with antibody targeted viral peptide/HLA-A2 complex.

  2010cited by this paper
• Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.

  2009cited by this paper
• Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.

  2009cited by this paper
• Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.

  2009cited by this paper
• Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation.

  2008cited by this paper
• Lipid-based Nanoparticles for Nucleic Acid Delivery

  2007influential reference
• Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.

  2005cited by this paper
• Post-operative serum sialyltransferase levels and prognosis in breast cancer

  2005cited by this paper
• PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.

  2004cited by this paper
• Endocytosis and Signal Transduction: Basic Science Update

  2003cited by this paper
• Pegylation: engineering improved pharmaceuticals for enhanced therapy.

  2002cited by this paper
• Total assignment of 1H and 13C NMR spectra of 13α‐ and 13β‐estrone methyl ethers

  2001cited by this paper
• Relationship of Skeletal Muscle Atrophy to Functional Status: A Systematic Research Review

  2000cited by this paper
• Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

  1999cited by this paper
• A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs

  1999cited by this paper
• Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.

  1996cited by this paper
• Mitoxantrone

  1996cited by this paper
• Soluble polymers for lectin-mediated drug targeting

  1994cited by this paper
• Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

  1991cited by this paper
• Solute and penetrant diffusion in swellable polymers: VI. The Deborah and swelling interface numbers as indicators of the order of biomolecular release

  1986cited by this paper
• The reactivities of the lysine, cysteine and tyrosine residues of pig heart lactate dehydrogenase in the presence of sulphite

  1968cited by this paper
• International Journal of Nanomedicine Dovepress Luteinizing Hormone-releasing Hormone Receptor-mediated Delivery of Mitoxantrone Using Lhrh Analogs Modified with Pegylated Liposomes

  year unknowncited by this paper

• Antitumour and anti-angiogenesis efficacy of a multifunctional self-oxygenated active-targeting drug delivery system by encapsulating biological and chemotherapeutic drugs.

  2025cites this paper
• Antitumor Efficacy, Pharmacokinetics, and Toxicity Studies of Novel Estrogen Receptors Targeted PEGylated Liposomes Encapsulating Paclitaxel and Cisplatin in SKOV‑3 Tumor-Bearing Nude Mice, ICR Mice, and SD Rats

  2025cites this paper
• Cytostatic drug mitoxantrone delivery platform based on porous vaterite particles: Synthesis, characterization and release

  2024cites this paper
• Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging

  2024cites this paper
• Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis

  2023cites this paper
• Efficient Delivery of Gemcitabine by Estrogen Receptor-Targeted PEGylated Liposome and Its Anti-Lung Cancer Activity In Vivo and In Vitro

  2023cites this paper
• A novel estrogen-targeted PEGylated liposome co-delivery oxaliplatin and paclitaxel for the treatment of ovarian cancer.

  2023cites this paper
• Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs

  2022cites this paper
• Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer.

  2022cites this paper
• An in vitro evaluation of antitumor activity of sirolimus-encapsulated liposomes in breast cancer cells.

  2021cites this paper
• In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer

  2021cites this paper
• Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges

  2021cites this paper
• Estrone-targeted liposomes for mitoxantrone delivery via estrogen receptor: In vivo targeting efficacy, antitumor activity, acute toxicity and pharmacokinetics.

  2021cites this paper
• Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylatedliposomal nanoparticle for breast cancer.

  2020cites this paper
• Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy.

  2019cites this paper
• Corrigendum

  2018cites this paper